Markets
The Origin of CFDs: A British Invention Born from a Tax Loophole
Contracts for Difference weren't originally designed as a global retail trading product — they emerged in London in the early 1990s largely as a tool for institutional investors to hedge stock positions without paying UK…
Frankfurt Stocks Rebound as Oil Prices Retreat From Middle East Tensions
Falling crude eased inflation worries and lifted the DAX 0.6% to 25,739; the MDax gained 1.7% to 31,764 amid geopolitical developments and strong US tech gains.
Oil Prices Drop Below $100 as Middle East Supply Risks Ease
Brent fell below $100 on signs of U.S.-Iran diplomatic progress and an Iranian proposal to reopen the Strait of Hormuz, even as Saudi output rises and freight costs remain strained.
US Stocks Expected to Hold Gains, Oil Price Support Seen
US stock indices are likely to maintain their gains from Monday, with falling oil prices providing support. The Nasdaq 100 is close to its record high, while the Dow Jones Industrial Average is expected to rise slightly.
European stocks climb as oil prices fall, M&A buzz lifts Evonik
Fallen crude prices and Middle East diplomacy boost European equities, while KI enthusiasm and takeover speculation add further gains.
On surges on buyback and guidance; US markets edge higher ahead of earnings
US futures opened narrowly; Swiss SMI rose 0.4%. On lifted 6% on a $1B buyback and 2029 revenue target of at least CHF 5.6bn.
FDA Approves Phase 2 Trial for Palisade Bio's Crohn's Disease Drug
Palisade Bio's PDE4 inhibitor prodrug, PALI-2108, advances to Phase 2 trial for moderate to severe Crohn's disease, with first patient dosing targeted for Q1 2027.
CME Group to launch Bitcoin Cash and Uniswap futures
CME Group will add Bitcoin Cash and Uniswap futures to its Globex platform on Oct. 19, offering standard and micro contracts alongside its existing crypto lineup.
FDA Demands Survival Trial for Compass’ Tovecimig in BTC Cancer
Compass Therapeutics faces FDA push for an additional survival study before seeking approval of tovecimig in advanced biliary tract cancer, despite existing Phase 2/3 trial results.
Nativo Resources Reports Progress at Peru Gold Operations
The Perth-based explorer said surface sampling confirmed high-grade gold mineralization at its Bonanza mine and secured project finance for the La Patona processing plant in its half-year results.
FDA Fast-Track Approval for Quoin’s Peeling Skin Therapy
Quoin Pharmaceuticals Ltd. received fast-track designation from the FDA for QRX003, an investigational lotion targeting Peeling Skin Syndrome and Netherton Syndrome.
Investing.com Unveils WarrenAI 2.0 With Live Research Panel
The platform launches an upgraded AI research tool alongside performance data from its ProPicks strategies, which have outperformed benchmarks by 21% to 112%.
Iran signals Hormuz Strait reopening if US lifts sanctions
Diplomatic efforts intensify ahead of UN General Debate amid geopolitical tensions over regional trade routes and oil supply chains.
Bank of America Raises Brent Oil Forecast to $95 on Geopolitical Risks
BofA lifts H2 Brent outlook to $95 a barrel from $83 as Strait of Hormuz disruptions and Middle East tensions underpin the revised estimate.
Repetitive $5,499 Trades Dominate Kalshi Ether Perpetual Volume
CoinDesk analysis finds fixed-dollar algorithmic trades account for more than half of sampled bitcoin and ether perpetual-futures volume on the CFTC-regulated exchange.
Saudi Aramco eyes Yanbu restart, signaling a potential reopening of the Saudi oil lifeline
Saudi Aramco is reportedly evaluating a restart of its Yanbu facility, which could reopen the Saudi oil lifeline.
Mizuho Ups Meta Price Target to $750, Sees Bull Case Playing Out
Mizuho analyst Lloyd Walmsley raises Meta's price target to $750, citing rapid growth of Muse AI agent and upcoming Meta Connect event as evidence of a bullish outlook.
Houdini Swap Crosses $3 Billion in Cumulative Volume
The non-custodial cross-chain aggregator, now a wholly-owned subsidiary of SOL Strategies, has processed more than $260 million since its June acquisition.
Standard Chartered CEO Highlights Growth, AI Push Amid Caution at Bank of America Conference
Bill Winters outlines strategic priorities, including AI-driven efficiency and risk management, while maintaining income growth targets and operational resilience.
Aprea Therapeutics to present APR-1051 Phase 1 data at Barcelona symposium
Aprea Therapeutics (NASDAQ: APRE) will share interim Phase 1 results of its WEE1 inhibitor APR-1051 at the EORTC‑NCI‑AACR symposium in Barcelona on Nov 20, 2026.
Playtech COO Acquires 110,806 Shares via Options Exercise
Shimon Akad, COO of Playtech plc, exercised options to acquire 110,806 shares on September 17, 2024, under the Playtech Long Term Incentive Plan 2022.
Nuburu aims to close 70% Tekne acquisition by early October 2026
Nuburu announced it will acquire a controlling 70% stake in Italian defence firm Tekne S.p.A., targeting completion in early October 2026 after receiving Golden Power clearance and providing €7 million toward the €9 million closing requirement.
Incyte to Share Inflammation Data at Vienna Dermatology Congress
Incyte Corp. will present clinical findings on ruxolitinib cream and povorcitinib at the EADV Congress in Vienna, focusing on dermatological conditions like atopic dermatitis and hidradenitis suppurativa.
Evonik shares jump 4.8% on BASF merger talk reports
Evonik stock rose nearly 5% after media cited Dealreporter and Mergermarket reports of BASF discussions on a possible transaction, while the firm continues its restructuring plan.
Swiss franc rallies as USD/CHF drops below 0.8200, SNB warns of FX intervention
The Swiss franc strengthened against the dollar, with the pair slipping below 0.8200, while the SNB signaled readiness to intervene amid heightened Middle East risk.